Your browser doesn't support javascript.
loading
Results of Multicenter Phase II Study With Imatinib Mesylate in Allogeneic Recipients With Steroid-Refractory Chronic GVHD.
Baek, Dong Won; Cho, Hee Jeong; Kim, Ju-Hyung; Ahn, Jae Sook; Kim, Hyeoung-Joon; Lim, Sung Nam; Cheong, Jun Won; Kim, Sung-Yong; Lee, Ho Sup; Won, Jong Ho; Yhim, Ho-Young; Sohn, Sang Kyun; Moon, Joon Ho.
Afiliação
  • Baek DW; Department of Hematology-Oncology, Kyungpook National University Hospital, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.
  • Cho HJ; Department of Hematology-Oncology, Kyungpook National University Hospital, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.
  • Kim JH; Department of Hematology-Oncology, Kyungpook National University Hospital, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.
  • Ahn JS; Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Hwasun-gun, South Korea.
  • Kim HJ; Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Hwasun-gun, South Korea.
  • Lim SN; Department of Hematology-Oncology, Inje University Haeundae Paik Hospital, Pusan, South Korea.
  • Cheong JW; Department of Hematology-Oncology, Severance Hospital, Yonsei University Medical School, Seoul, South Korea.
  • Kim SY; Division of Hematology, Department of Internal Medicine, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul, South Korea.
  • Lee HS; Department of Hematology-Oncology, Kosin University Gospel Hospital, Pusan, South Korea.
  • Won JH; Department of Hematology-Oncology, SoonChunHyang University Hospital, Seoul, South Korea.
  • Yhim HY; Department of Internal Medicine, Jeonbuk National University Medical School, Jeonju, Korea.
  • Sohn SK; Department of Hematology-Oncology, Kyungpook National University Hospital, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.
  • Moon JH; Department of Hematology-Oncology, Kyungpook National University Hospital, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.
Cell Transplant ; 31: 9636897221113789, 2022.
Article em En | MEDLINE | ID: mdl-35861214

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Doença Enxerto-Hospedeiro Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Doença Enxerto-Hospedeiro Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article